1. Home
  2. ICLR

ICLR

ICON plc

Logo ICON plc

Health Care

Biotechnology: Commercial Physical & Biological Resarch

Nasdaq

as 04-15-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Founded: 1990 Country:
Ireland
Ireland
Employees: N/A City: N/A
Market Cap: 25.2B IPO Year: 1998
Target Price: $320.80 AVG Volume (30 days): 534.9K
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 7.40 EPS Growth: 20.72
52 Week Low/High: $181.92 - $344.77 Next Earning Date: 04-24-2024
Revenue: $8,120,176,000 Revenue Growth: 4.89%
Revenue Growth (this year): 8.48% Revenue Growth (next year): 7.30%

Share on Social Networks: